A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/9669564/ below:

Chronic disease as a barrier to breast and cervical cancer screening

doi: 10.1046/j.1525-1497.1998.00115.x. Chronic disease as a barrier to breast and cervical cancer screening

Affiliations

Affiliation

Item in Clipboard

Chronic disease as a barrier to breast and cervical cancer screening

C I Kiefe et al. J Gen Intern Med. 1998 Jun.

doi: 10.1046/j.1525-1497.1998.00115.x. Affiliation

Item in Clipboard

Abstract

Objective: To assess whether chronic disease is a barrier to screening for breast and cervical cancer.

Design: Structured medical record review of a retrospectively defined cohort.

Setting: Two primary care clinics of one academic medical center.

Patients: All eligible women at least 43 years of age seen during a 6-month period in each of the two study clinics (n = 1,764).

Measurements and main results: Study outcomes were whether women had been screened: for mammogram, every 2 years for ages 50-74; for clinical breast examinations (CBEs), every year for all ages; and for Pap smears, every 3 years for ages under 65. An index of comorbidity, adapted from Charlson (0 for no disease, maximum index of 8 among our patients), and specific chronic diseases were the main independent variables. Demographics, clinic use, insurance, and clinical data were covariates. In the appropriate age groups for each test, 58% of women had a mammogram, 43% had a CBE, and 66% had a Pap smear. As comorbidity increased, screening rates decreased (p < .05 for linear trend). After adjustment, each unit increase in the comorbidity index corresponded to a 17% decrease in the likelihood of mammography (p = .005), 13% decrease in CBE (p = .006), and 20% decrease in Pap smears (p = .002). The rate of mammography in women with stable angina was only two fifths of that in women without.

Conclusions: Among women who sought outpatient care, screening rates decreased as comorbidity increased. Whether clinicians and patients are making appropriate decisions about screening is not known.

PubMed Disclaimer

Figures

Figure 1

Proportion of women in appropriate…

Figure 1

Proportion of women in appropriate age group who were screened by Charlson comorbidity…

Figure 1

Proportion of women in appropriate age group who were screened by Charlson comorbidity category. See Methods section for definitions.

Comment in Similar articles Cited by References
    1. La Vecchia C, Decarli A, Gentile A, et al. Pap smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984;2:779–82. - PubMed
    1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273(2):149–54. - PubMed
    1. US Preventive Services Task Force . Guide to Clinical Prevention Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
    1. Anderson LM, May DS. Has the use of the cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85(6):840–2. - PMC - PubMed
    1. Trends in cancer screening–-United States, 1987 and 1992. MMWR. 1996;45(3):57–61. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3